Our consortial project GeNeRARe has been approved for a second funding period.

In GeNeRARe we investigate activating mutations of the RAS signalling pathway that lead to different form of a group of rare genetic disorders, so-called RASopathies, including Noonan Syndrome, Costellos Syndrome and others. We are interested in the mechanisms that result in intellectual disabilities in these disturbances and investigate the underlying neuronal dysfunction.

Leave a Reply

Your email address will not be published. Required fields are marked *